Trials / Conditions / Relapsed or Refractory Non-Hodgkin Lymphoma
Relapsed or Refractory Non-Hodgkin Lymphoma
3 registered clinical trials studyying Relapsed or Refractory Non-Hodgkin Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin NCT06845241 | Beijing InnoCare Pharma Tech Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lympho NCT05564806 | Eucure (Beijing) Biopharma Co., Ltd | Phase 1 |
| Terminated | Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, NCT03755154 | Institut de Recherches Internationales Servier | Phase 1 |